Biophytis S.A.
BPTS · NASDAQ
6/30/2024 | 12/31/2023 | 6/30/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $1 | $0 | $1 |
| Gross Profit | $0 | -$1 | -$0 | -$1 |
| % Margin | – | – | – | – |
| R&D Expenses | $3 | $6 | $5 | $10 |
| G&A Expenses | $2 | $3 | $3 | $2 |
| SG&A Expenses | $2 | $3 | $3 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$1 | -$1 | $0 | $0 |
| Operating Expenses | $4 | $8 | $7 | $11 |
| Operating Income | -$4 | -$8 | -$7 | -$11 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$1 | -$1 | -$1 | -$0 |
| Pre-Tax Income | -$6 | -$9 | -$8 | -$12 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$6 | -$9 | -$8 | -$12 |
| % Margin | – | – | – | – |
| EPS | -1.66 | -5.14 | -9.5 | -25.1 |
| % Growth | 67.7% | 45.9% | 62.2% | – |
| EPS Diluted | -1.66 | -4.88 | -9.48 | -23.42 |
| Weighted Avg Shares Out | 3 | 2 | 1 | 0 |
| Weighted Avg Shares Out Dil | 3 | 2 | 1 | 1 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $2 |
| Interest Expense | $0 | $1 | $2 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$4 | -$7 | -$6 | -$11 |
| % Margin | – | – | – | – |